IBDEI0NK ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10608,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,10608,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,10609,0)
 ;;=G31.09^^42^472^20
 ;;^UTILITY(U,$J,358.3,10609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10609,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,10609,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,10609,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,10610,0)
 ;;=F02.81^^42^472^37
 ;;^UTILITY(U,$J,358.3,10610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10610,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10610,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10610,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10611,0)
 ;;=F02.80^^42^472^38
 ;;^UTILITY(U,$J,358.3,10611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10611,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10611,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10611,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10612,0)
 ;;=F02.81^^42^472^43
 ;;^UTILITY(U,$J,358.3,10612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10612,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10612,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10612,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10613,0)
 ;;=F02.80^^42^472^44
 ;;^UTILITY(U,$J,358.3,10613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10613,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10613,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10613,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10614,0)
 ;;=G31.84^^42^472^59
 ;;^UTILITY(U,$J,358.3,10614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10614,1,3,0)
 ;;=3^Mild Neurocog D/O d/t FRONTOTEMP LOBAR DEGEN
 ;;^UTILITY(U,$J,358.3,10614,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10614,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10615,0)
 ;;=F02.81^^42^472^27
 ;;^UTILITY(U,$J,358.3,10615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10615,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10615,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10615,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10616,0)
 ;;=F02.80^^42^472^28
 ;;^UTILITY(U,$J,358.3,10616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10616,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10616,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10616,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10617,0)
 ;;=G31.84^^42^472^60
 ;;^UTILITY(U,$J,358.3,10617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10617,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HIV INFECTION
 ;;^UTILITY(U,$J,358.3,10617,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10617,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10618,0)
 ;;=F02.81^^42^472^29
 ;;^UTILITY(U,$J,358.3,10618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10618,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10618,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10618,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10619,0)
 ;;=F02.80^^42^472^30
 ;;^UTILITY(U,$J,358.3,10619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10619,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10619,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10619,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10620,0)
 ;;=G31.84^^42^472^61
